We thus compared all Smarcb1-deficient (from Smarcb1wt/del_ex1-2 and Smarcb1flox/flox;Rosa26-CreERT2 models, that is, lymphomas, intracranial tumours and extracranial tumours) and non Smarcb1-deficient mouse tumours aforementioned (medulloblastomas and neuroblastomas). Here, SMARCB1 is linked to lymphoma.